Grants paid by A Cure in Our Lifetime Inc
EIN 27-4736026 · Chappaqua, NY · Form 990, Schedule I · NTEE G123
A Cure in Our Lifetime Inc of Chappaqua, NY (EIN 27-4736026) reported 23 grants paid totaling $2,675,334 to 5 recipients in tax years 2018–2025, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$2,675,334
23 grants
Recipients
5
distinct organizations
Tax years
2018–2025
8 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 3 | $355,000 | — |
| 2019 | 3 | $316,667 | — |
| 2020 | 3 | $192,667 | — |
| 2021 | 2 | $250,000 | — |
| 2022 | 2 | $200,000 | — |
| 2023 | 4 | $490,000 | — |
| 2024 | 4 | $390,000 | — |
| 2025 | 2 | $481,000 | — |
Top recipients
The 5 recipients receiving the most from A Cure in Our Lifetime Inc, by grants paid, out of 5 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Breast Cancer Research Founda 13-3727250 | A | New York, NY | 11 | $1,771,500 | 2025 |
| Emory Windship Cancer Institu 58-0566256 | A | Atlanta, GA | 7 | $735,500 | 2025 |
| Its the Journey 47-0897591 | A | Atlanta, GA | 1 | $75,000 | 2018 |
| Mtsinai Medical Center 13-6171197 | A | New York, NY | 2 | $60,000 | 2024 |
| Morehouse School of Medicine 58-1438873 | A | Atlanta, GA | 2 | $33,334 | 2020 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 23 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Breast Cancer Research Founda New York, NY | A | $313,500 | paid | Breast Cancer Research | 202611619349300526 |
| 2025 | Emory Windship Cancer Institu Atlanta, GA | A | $167,500 | paid | Breast Cancer Research | 202611619349300526 |
| 2024 | Emory Windship Cancer Institu Atlanta, GA | A | $130,000 | paid | Breast Cancer Research | 202532949349301353 |
| 2024 | Breast Cancer Research Founda New York, NY | A | $130,000 | paid | Breast Cancer Research | 202532949349301353 |
| 2024 | Breast Cancer Research Founda New York, NY | A | $100,000 | paid | Breast Cancer Research | 202532949349301353 |
| 2024 | Mtsinai Medical Center New York, NY | A | $30,000 | paid | Breast Cancer Research | 202532949349301353 |
| 2023 | Breast Cancer Research Founda New York, NY | A | $130,000 | paid | Breast Cancer Research | 202442719349301719 |
| 2023 | Breast Cancer Research Founda New York, NY | A | $125,000 | paid | Breast Cancer Research | 202442719349301719 |
| 2023 | Emory Windship Cancer Institu Atlanta, GA | A | $125,000 | paid | Breast Cancer Research | 202442719349301719 |
| 2023 | Breast Cancer Research Founda New York, NY | A | $110,000 | paid | Breast Cancer Research | 202442719349301719 |
| 2022 | Emory Windship Cancer Institu Atlanta, GA | A | $100,000 | paid | Breast Cancer Research | 202342239349301304 |
| 2022 | Breast Cancer Research Founda New York, NY | A | $100,000 | paid | Breast Cancer Research | 202342239349301304 |
| 2021 | Breast Cancer Research Founda New York, NY | A | $175,000 | paid | RESEARCH | 202221359349300512 |
| 2021 | Emory Windship Cancer Institu Atlanta, GA | A | $75,000 | paid | RESEARCH | 202221359349300512 |
| 2020 | Emory Windship Cancer Institu Atlanta, GA | A | $88,000 | paid | RESEARCH | 202131029349300403 |
| 2020 | Breast Cancer Research Founda New York, NY | A | $88,000 | paid | RESEARCH | 202131029349300403 |
| 2020 | Morehouse School of Medicine Atlanta, GA | A | $16,667 | paid | RESEARCH | 202131029349300403 |
| 2019 | Breast Cancer Research Founda New York, NY | A | $250,000 | paid | RESEARCH | 202020849349300102 |
| 2019 | Emory Windship Cancer Institu Atlanta, GA | A | $50,000 | paid | RESEARCH | 202020849349300102 |
| 2019 | Morehouse School of Medicine Atlanta, GA | A | $16,667 | paid | RESEARCH | 202020849349300102 |
| 2018 | Breast Cancer Research Founda New York, NY | A | $250,000 | paid | RESEARCH | 201941719349300119 |
| 2018 | Its the Journey Atlanta, GA | A | $75,000 | paid | RESEARCH | 201941719349300119 |
| 2018 | Mt Sinai Medical Center - Dub New York, NY | A | $30,000 | paid | RESEARCH | 201941719349300119 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2025 | 2025-12-31 | not stated | 2025v4.1 | 202611619349300526 |
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202532949349301353 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202442719349301719 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202342239349301304 |
| 990 | 2021 | 2021-12-31 | not stated | 2021v4.0 | 202221359349300512 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.0 | 202131029349300403 |
| 990 | 2019 | 2019-12-31 | not stated | 2019v5.0 | 202020849349300102 |
| 990 | 2018 | 2018-12-31 | not stated | 2018v3.1 | 201941719349300119 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/274736026.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.